Eurobio Scientific SA
PAR:ALERS

Watchlist Manager
Eurobio Scientific SA Logo
Eurobio Scientific SA
PAR:ALERS
Watchlist
Price: 25.75 EUR -0.19% Market Closed
Market Cap: 257.6m EUR
Have any thoughts about
Eurobio Scientific SA?
Write Note

Relative Value

The Relative Value of one ALERS stock under the Base Case scenario is 29.72 EUR. Compared to the current market price of 25.75 EUR, Eurobio Scientific SA is Undervalued by 13%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALERS Relative Value
Base Case
29.72 EUR
Undervaluation 13%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
6
vs Industry
85
Median 3Y
1.3
Median 5Y
1.3
Industry
8.1
Forward
2
vs History
3
vs Industry
5
Median 3Y
8.2
Median 5Y
6.2
Industry
23
Forward
31
vs History
25
vs Industry
13
Median 3Y
4.7
Median 5Y
5.6
Industry
23.4
vs History
1
vs Industry
4
Median 3Y
4.1
Median 5Y
3.6
Industry
27.3
vs History
30
vs Industry
59
Median 3Y
1.2
Median 5Y
1.5
Industry
2.6
vs History
6
vs Industry
74
Median 3Y
1.3
Median 5Y
1.2
Industry
8.1
Forward
2
vs History
11
vs Industry
65
Median 3Y
2.8
Median 5Y
2.7
Industry
9.6
vs History
7
vs Industry
11
Median 3Y
5.4
Median 5Y
5.4
Industry
4.3
Forward
9.9
vs History
11
vs Industry
8
Median 3Y
7
Median 5Y
7
Industry
3.8
Forward
11.6
vs History
25
vs Industry
13
Median 3Y
5
Median 5Y
5.8
Industry
6
vs History
25
vs Industry
10
Median 3Y
5.4
Median 5Y
6.8
Industry
3.8
vs History
46
vs Industry
60
Median 3Y
0.9
Median 5Y
1.3
Industry
4.8

Multiples Across Competitors

ALERS Competitors Multiples
Eurobio Scientific SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Eurobio Scientific SA
PAR:ALERS
281.3m EUR 1.9 42.3 9.9 20.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
300.2B USD 5.4 59 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
159.1B USD 4.9 37.4 17.5 33.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.6B USD 11.9 -263.9 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
114.6B USD 4.1 910.1 10.1 10.1
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
137.3B AUD 6 33.7 20.8 25.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
87.6B USD 6.3 18.8 17.3 19.2
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
FR
Eurobio Scientific SA
PAR:ALERS
Average P/E: 183.6
42.3
203%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.9
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.1
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.7
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
18.8
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
FR
Eurobio Scientific SA
PAR:ALERS
Average EV/EBITDA: 16.7
9.9
26%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.8
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.3
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
FR
Eurobio Scientific SA
PAR:ALERS
Average EV/EBIT: 22.8
20.3
121%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.2
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.1
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
25.9
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.2
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top